Understanding HIV prevention preferences among Liberian adolescent girls and young women
HIV PrEP Perspectives of Liberian Adolescent Girls and Young Women and their Providers
This study is talking to young women and girls in Liberia to learn what they think about using a medicine called PrEP that helps prevent HIV, so we can better understand what encourages them to use it and what challenges they face in getting it.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10788449 on NIH RePORTER |
What this research studies
This research investigates the perspectives of adolescent girls and young women in Liberia regarding Pre-Exposure Prophylaxis (PrEP), a preventive treatment for HIV. It aims to understand the factors influencing their willingness to use PrEP and the barriers they face in accessing it. By engaging with both the young women and their healthcare providers, the study seeks to gather insights that can inform the development of tailored PrEP programs that meet the specific needs of this population. The research will involve qualitative interviews and surveys to capture a comprehensive view of attitudes and decision-making processes related to HIV prevention.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescent girls and young women in Liberia who are at risk of HIV infection.
Not a fit: Patients who are not at risk of HIV or those outside the age range of adolescent girls and young women may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and accessible HIV prevention strategies for adolescent girls and young women in Liberia.
How similar studies have performed: Other research has shown success in understanding PrEP uptake in different populations, but this specific focus on Liberian adolescent girls and young women is relatively novel.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Wohl, David a — Univ of North Carolina Chapel Hill
- Study coordinator: Wohl, David a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.